Studying Responses to COVID-19 Infection or Treatment?
BioXpedia’s laboratory offers analysis services on several levels for research projects investigating infection and disease caused by SARS-CoV-2.
Screening plasma samples for relevant proteins in relation to infection/non-infection or treatment response:
To gather knowledge about the virus’ impact on the immune- or inflammatory response, the relative concentration of proteins known to be related to immune or inflammatory response, can be measured in plasma or serum samples. Such data may even contain information useful for prognostic purposes or stratification of patients.
We use the Olink Immuno-PCR panels, each containing 92 protein assays, to screen plasma or serum samples. Only 1 µl of sample is required for the antibody-based screening. To learn more about the technology, the panels, and protein markers we screen for, please see panels
To get in contact with us, mail to [email protected] or call us.
Screening plasma samples for immune response
Gene expression related to immune response
Gene Expression Analysis related to Immune and Inflammatory Response:
To achieve understanding of the biological response to the virus, or the effects related to treatment, gene expression profiling is a valuable tool.
For analysis of samples we use NanoString’s technology. Panels of up to 770 gene assays, can elucidate patterns of gene expression related to immune and inflammatory responses associated with infection. In addition NanoString has developed a spike-in panel of gene expression assays for SARS-CoV-2. Using the spike-in option, the infection and immune response can be studied simultaneously.
For more info on the NanoString technology and panels, please see more about nanostring
We also offer investigation of specific gene targets. This is done by Q-PCR in a flexible set-up, using the Fluidigm Biomark HD system. For more details see high-through-put Q-PCR
For any information regarding our Gene Expression Analysis services please contact us by phone or mail [email protected].
Investigation of known SNP genotypes related to symptomatic/non-symptomatic cases:
To understand the variation in symptoms related to virus infection, researchers might look at specific SNPs in the human genome to evaluate their hypothesis.
To analyse samples for targeted SNP genotyping we offer a high-through-put analysis, with the option to analyse 24 or 96 different SNPs per sample. Our capacity for SNP genotyping is > 50.000 samples per month.
For more information about SNP genotyping options, please go to snp-genotyping.
Detection of SARS-CoV-2 using Q-PCR
Detection of SARS-CoV-2 in samples using Q-PCR:
BioXpedia now also offer testing of SARS-CoV-2. For detection, we extract RNA from samples and run Q-PCR analysis for genes specific for SARS-CoV-2 + controls. Up to 24 target genes total can be detected per sample allowing testing for additional viral respiratory diseases. We use the Fluidigm Biomark HD system for Q-PCR, giving us the option of analyzing 190 samples versus 24 target genes in a single run.
For more information contact us by phone or mail [email protected].